Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Intermittent fasting is safe, effective for those with Type 2 diabetes, study suggests

Time-restricted eating, also known as intermittent fasting, can help people with Type 2 diabetes lose weight and control their blood sugar levels, according to a new study published in JAMA Network Open from researchers at the University of Illinois Chicago. Participants who ate only during an eight-hour window between noon and 8 p.m. each day […]

The feeling of hunger itself may slow aging in flies

From low-carb to intermittent fasting, surgery to Ozempic — people turn to a seemingly never-ending array of diets, procedures and drugs to lose weight. While it has been long understood that limiting the amount of food eaten can promote healthy aging in a wide range of animals, including humans, a new study from University of […]

Intermittent fasting may reverse type 2 diabetes, according to study: Study finds people with diabetes who fast intermittently may no longer need medication

After an intermittent fasting diet intervention, patients achieved complete diabetes remission, defined as an HbA1c (average blood sugar) level of less than 6.5% at least one year after stopping diabetes medication, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Intermittent fasting diets have become popular in recent […]

Home Walking Program Eases Peripheral Artery Disease Limitations

Motivating patients with peripheral artery disease (PAD) and intermittent claudication to start walking at home improved their exercise capacity, the MOSAIC trial showed. Six-minute walk distance improved by 16.7 m more with the physical therapist-led intervention compared with usual care alone at 3 months (from 352.9 m at baseline to 380.6 m vs 369.8 to […]

Breast Cancer Control Similar With Intermittent, Continuous Endocrine Therapy

Intermittent or continuous extended adjuvant endocrine therapy led to virtually identical long-term survival in hormone receptor (HR)-positive breast cancer, according to an updated analysis of a randomized trial. Disease-free survival (DFS) at 7 years was 81.4% with intermittent extended letrozole and 81.5% with continuous treatment. The results mirrored previously reported 5-year DFS, which also did […]

DBN Health News